Alliancebernstein L.P. Regenxbio Inc. Transaction History

Alliancebernstein L.P.

$287 Billion
Q3 2024

A detailed history of Alliancebernstein L.P. transactions in Regenxbio Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 59,027 shares of RGNX stock, worth $564,298. This represents 0.0% of its overall portfolio holdings.

Number of Shares

59,027

Previous 59,027 -0.0%

Holding current value

$564,298

Previous $690,000 10.29%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$12.17 - $24.61 $6,243 - $12,624	-513 Reduced 0.86%	59,027 $1.24 Million
Q4 2023 Feb 14, 2024	SELL	$12.89 - $20.82 $15,210 - $24,567	-1,180 Reduced 1.94%	59,540 $1.07 Million
Q2 2023 Aug 15, 2023	SELL	$17.23 - $21.71 $861,500 - $1.09 Million	-50,000 Reduced 45.16%	60,720 $1.21 Million
Q1 2023 May 15, 2023	BUY	$18.08 - $24.55 $803,493 - $1.09 Million	44,441 Added 67.05%	110,720 $2.09 Million
Q4 2022 Feb 14, 2023	BUY	$20.4 - $24.73 $856 - $1,038	42 Added 0.06%	66,279 $1.5 Million
Q3 2022 Nov 15, 2022	SELL	$22.29 - $35.04 $44 - $70	-2 Reduced -0.0%	66,237 $1.75 Million
Q2 2022 Aug 15, 2022	SELL	$19.35 - $35.04 $27,128 - $49,126	-1,402 Reduced 2.07%	66,239 $1.64 Million
Q1 2022 May 13, 2022	BUY	$24.62 - $34.31 $3,791 - $5,283	154 Added 0.23%	67,641 $2.25 Million
Q4 2021 Feb 14, 2022	SELL	$30.19 - $40.28 $26,959 - $35,970	-893 Reduced 1.31%	67,487 $2.21 Million
Q3 2021 Nov 10, 2021	SELL	$29.09 - $45.68 $37,235 - $58,470	-1,280 Reduced 1.84%	68,380 $2.87 Million
Q2 2021 Jul 30, 2021	BUY	$32.46 - $40.48 $273,313 - $340,841	8,420 Added 13.75%	69,660 $2.71 Million
Q1 2021 May 06, 2021	BUY	$33.61 - $49.95 $66,211 - $98,401	1,970 Added 3.32%	61,240 $2.09 Million
Q3 2020 Nov 12, 2020	SELL	$27.01 - $40.26 $115,332 - $171,910	-4,270 Reduced 6.72%	59,270 $1.63 Million
Q2 2020 Aug 13, 2020	SELL	$27.75 - $43.44 $18,315 - $28,670	-660 Reduced 1.03%	63,540 $2.34 Million
Q1 2020 May 14, 2020	BUY	$21.5 - $54.2 $29,025 - $73,170	1,350 Added 2.15%	64,200 $2.08 Million
Q4 2019 Feb 18, 2020	BUY	$34.54 - $44.87 $6,908 - $8,974	200 Added 0.32%	62,850 $2.58 Million
Q3 2019 Nov 14, 2019	SELL	$31.84 - $50.88 $1.37 Million - $2.19 Million	-42,980 Reduced 40.69%	62,650 $2.23 Million
Q2 2019 Aug 14, 2019	BUY	$42.0 - $59.29 $1.04 Million - $1.47 Million	24,800 Added 30.68%	105,630 $5.43 Million
Q1 2019 May 14, 2019	SELL	$40.82 - $62.45 $4.05 Million - $6.19 Million	-99,100 Reduced 55.08%	80,830 $4.63 Million
Q4 2018 Feb 13, 2019	BUY	$39.11 - $75.15 $4.09 Million - $7.85 Million	104,510 Added 138.57%	179,930 $7.55 Million
Q3 2018 Nov 08, 2018	SELL	$65.0 - $82.15 $1.03 Million - $1.3 Million	-15,810 Reduced 17.33%	75,420 $5.69 Million
Q2 2018 Aug 13, 2018	BUY	$27.2 - $74.35 $1.74 Million - $4.75 Million	63,830 Added 232.96%	91,230 $6.55 Million
Q3 2017 Nov 13, 2017	BUY	$18.0 - $32.95 $493,200 - $902,830	27,400	27,400 $903,000

Others Institutions Holding RGNX

# of Institutions

197

Shares Held

43.2M

Call Options Held

104K

Put Options Held

478K

View Full List

About REGENXBIO Inc.

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $413M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

More about RGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Regenxbio Inc. Transaction History